Skip to main content

Table 3 Factors affecting the overall survival after hypofractionated radiotherapy

From: Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma

Variables Univariate analysis Multivariate analysis
HR 95% CI P value HR 95% CI P value
Sex 1.05 0.60–1.83 0.876    
Age 1.02 0.99–1.05 0.144 1.03 0.99–1.06 0.080
ECOG PS (0–1 vs. 2–3) 1.30 0.51–3.28 0.581    
Tumor size 1.23 0.96–1.58 0.101 1.24 0.95–1.61 0.119
Alpha-fetoprotein (log10) 1.24 0.92–1.67 0.154 1.17 0.86–1.59 0.323
Child-Pugh class 1.20 0.65–2.21 0.570    
Number of previous treatment sessions 1.10 1.03–1.17 0.007 1.08 1.01–1.16 0.029
Dose (50 Gy vs. < 50 Gy) 1.03 0.98–1.08 0.310    
  1. HR hazard ratio, CI confidence interval, ECOG Eastern Cooperative Oncology Group, PS performance status